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57 ABSTRACT 
To produce doxorubicin and its analogues methyl 3al 
pha, 5alpha-dihydroxy-5beta-(trimethylsilylethynyl)- 
2alpha-nitromethylcyclohexane-1beta-carboxylate 
acetonide is condensed with 1,4-dihydro-4,4,5-trime 
thoxy-1-oxonaphthalene in the presence of 1,8- 
diazabicyclo-5.4.0]undec-7-ene in an aprotic solvent to 
produce 3-(2beta-carbomethoxy-4-beta-ethynyl-4-alpha, 
6alpha-(di-O-isopropylidenyl)cyclohexanyl-1-yl)- 
nitromethyl-4,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahy 
dronaphthalene; which is cyclized to produce 9beta 
ethynyl-12-hydroxy-7alpha,9alpha-(di-O-iso 
propylidenyl)-6-nitro-4,5,5-trimethoxy-5,5a,6- 
6a,7,8,9,10,10a,11-decahydro -11-naphthacenone. The 
decahydro-11-naphthacenone is converted to 7alpha 9alpha,(di-O-isopropyl-idenyl)-4,5-dimethoxy-9beta 
ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,10a, 11 
octahydro-11, -naphthacenone. The octahydro-11 
naphthacenone is oxidized to 7alpha-9alpha, (di-O-iso 
propyl-idenyl)-9beta-ethynyl-11-hydroxy-4-methoxy-6- 
nitro-7,8,9,10-tetrahydro-5,12-naphthacenedione 
which is converted to 6-desoxy-6-nitrodaunomycinone, 
daunomycinone and related 6-substituted analogues of 
daunomycinone. 
37 Claims, No Drawings 
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1. 
PROCESSES FOR PRODUCING DOXORUBICIN, 
DAUNOMYCINONE, AND DERIVATIVES OF 
DOXORUBCN 
BACKGROUND OF THE INVENTION 
This invention relates to a process for producing 
doxorubicin (adriamycin), and derivatives of doxorubi 
cin, through a novel synthesis of daunomycinone and its 
derivatives. These mycinones can be coupled by known 
methods to daunosamine to produce doxorubicin and its 
corresponding derivatives. 
It is known that doxorubicin is isolated from Strepto 
myces peucetius. A suitable process for this isolation is 
described by F. Arcamone, in "Duxorubicin Anticancer 
Antibiotics,” (Academic Press, New York (1981). 
Moreover, synthetic routes to doxorubicin are known 
and these are summarized, for example, by F. Arca 
mone (loc. cit.), K. Krohn, Angew. Chem. Int, Ed. Engl, 
volume 25 (1986), page 790 and Tetrahedron, volume 46 (1989), page 291 and T. R. Kelly, Tetrahedron Symposi 
um-in-Print, volume 40 (1984), pages 4537-4793. 
A representative prior art procedure for converting 
daunomycinone to adriamycin is that proposed by Ar 
camone et al., U.S. Pat. No. 3,803,124. The prior art 
methods of obtaining daunomycinone have the disad 
vantage of being expensive. 
SUMMARY OF THE INVENTION 
It is an object of the invention to provide a novel 
synthesis of doxorubicin. 
It is a still further object of the invention to provide a 
novel process for synthesis of derivatives of doxorubi 
C. 
It is a still further object of the invention to provide a 
novel process for the synthesis of doxorubicin and its 
derivatives in which the A ring is made stereo selec 
tively with its functionality already established and then joined to the CD portion, with the relationship between 
the C-7 and C-9 hydroxyls established stereoselectively 
before the tetracyclic skeleton is constructed. 
It is a still further object of the invention to provide a 
novel process for the synthesis of daunomycinone that 
proceeds in DCAB order with the Bring formed last. 
It is a still further object of the invention to provide a 
novel process of producing intermediates for the syn 
thesis of daunomycinone, namely, methyl 3alpha,5al 
pha-dihydroxy-5beta-(trimethylsilylethynyl)-2alpha 
nitromethylcyclohexane-1-beta-carboxylate and the 
3,5-acetonide of methyl 3alpha,5alpha-dihydroxy 5beta-(tri-methylsilylethynyl)-2alpha-nitromethylcy 
clohexane-1-betacarboxylate. 
It is a still further object of the invention to provide 
novel synthetic routes to daunomycinone and deriva 
tives of this compound. 
In accordance with the invention a novel synthesis of 
daunomycinone is provided in which the A-ring precur 
sor of the compound is synthesized from m-anisic acid. 
The A-ring precursor, methyl cis-2,3-epoxy-5-hydroxy 
5-(trimethylsilylethynyl)cyclohexane-1-carboxylate, is 
converted to methyl cis-3,5-dihydroxy-5-(trimethyl 
silylethynyl)cyclohex-1-ene-1-carboxylate which is ni 
tromethylated to produce the required 2alpha 
nitromethyl compound. The 3,5-acetonide of the 2al 
pha-nitromethyl compound is coupled with a juglone 
alkyl ether ketal and cyclized to a tetracyclic intermedi 
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2 
ate. The latter can be converted to daunomycinone and 
many of its derivatives. 
More specifically, this process for the production of 
daunomycinone, comprises the steps of: (1) condensing 
methyl 3alpha,5alpha-dihydroxy-5beta-(trimethylsilyle 
thynyl)-2alphanitromethylcyclohexane-1-beta-carboxy 
late acetonide with 1,4-dihydro-4,4,5-trimethoxy-1- 
oxonaphthalene in the presence of 1,8-diazabicy 
cloS.40-undec-7-ene in an aprotic solvent to produce 
a 3-(2beta-carbomethoxy-4-beta-ethynyl-4-alpha,6alpha (di-O-isopropylidene)cyclohexanyl-1-yl-nitromethyl 
44; 5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene; (2) cyclizing the thus-produced 1-oxotetrahydronaph 
thalene to produce 7alpha, 9alpha-(di-O-isopropylin denyl)-4-6-nitro-4,5,5-trimethoxy-5,5a,6,6a,7,8,9,10,- 
10a, 11-dechydro-11-naphthacenone; (3) converting 
the decahydro-11-naphthacenone to 4,5-dimethoxy-7al 
pha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl-12 hydroxy-6-nitro-6,6a,7,8,9,10,10a-octahydro-11-naph 
thacenone; (4) oxidizing the thus produced octahydro 
11-naphthacenone to 7alpha-9alpha-(di-O-isol 
propylidenyl)-9beta-ethynyl-l-hydroxy-4-methoxy-6- 
nitro-7,8,9,10-tetrahydro-5-12-naphthacenedione; (5) 
hydrolysing the tetrahydro-5,12-naphthacenedione to 
6-desoxy-6-nitro-daunomycinone; (6) reducing the nitro 
compound to 6-desoxy-6-aminodaunomycinone; (7) 
diazotising the amino compound and obtaining from it, 
daunomycinone, the 6-desoxy-6 halo and 
cyanodaunomycinones and compounds derived from 
them. 
To produce the methyl 3alpha,5alpha-dihydroxy-2al 
pha-nitromethyl-5beta-(trimethylsilylethynyl)cyclohex 
ane-1beta carboxylate, methyl cis-3,5-dihydroxy-5- (trimethylsilylethynyl)-cyclohex-1-ene-1-carboxylate is 
reacted with nitromethane in the presence of 1,8- 
diazabicyclo[5.4.0]undec-7-ene or sodium hydride in an 
aprotic solvent that can act as a hydrogen bond accep 
tor. 
To synthesize methyl cis-3,5-dihydroxy-5-(trimethyl 
silylethynyl)cyclohex-1-ene-1-carboxylate, m-anisic 
acid is subject to the Birch reduction with lithium in 
ammonia to produce 5-oxocyclohex-2-ene-1-carboxylic 
acid, followed by methylation of thusproduced cy 
clohex-2-ene-1-carboxylic acid to methyl 5-oxocy 
clohex-2-ene-1-carboxylate with diazomethane, trime 
thylsilyl-ethynylation of thus-produced cyclohex-2-ene 
1-carboxylate with cerium dichloride trimethylsilylace 
tylene to produce methyl cis-5-hydroxy-5-(trimethyl 
silylethynyl)cyclohex-2-ene-1-carboxylate, conversion 
to an epoxide and opening of the resulting epoxide ring 
to produce the cis-3,5-dihydroxy compound. 
In this process for synthesizing daunomycinone there 
are several especially significant procedural steps, such 
as: (1) the reaction mixture is kept between -20 to 20 
degrees centigrade during esterification with diazo 
methane; (2) any ethanol and water present in the esteri 
fication reaction mixture is removed by azeotropic dis 
tillation with benezene to produce methyl ester; (3) 
methyl ester is immediately treated with cerium dichlo 
ride trimethylsilylacetylene at a low temperature, such 
as -50 to -78 degrees centigrade, to prevent forma 
tion of a lactone; (4) the epoxide is formed by oxidation 
with tert-butylhydroperoxide in the presence of molyb 
denum hexacarbonyl catalyst and the epoxide that is 
produced is isolated; and (5) the thus-formed epoxide 
ring is opened with 1,8-diazabicyclo[5.4.0-undec-7-ene. 
The cerium reagent must be added to the keto ester to 
avoid a migration of the double bond. 
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A feature of the synthesis is the production of the 
4,4-dimethylacetal of 5-alkoxy-1,4-naphthoquinones 
oxidation of 5-alkoxy-1-naphthol with iodobenzene 
diacetate in methanol. The 5-alkoxy-1-naphthol, in 
which the alkoxy is of 1-6 carbon atoms as described in 
Moore, H. W.; Lee, S.; Rutolo, D.; Sheldon, R., J. Org. 
Chem., 1978, 43, 2304-2306. Generally, this process 
may include the steps of: (1) alkylating 1,5-dihydrox 
ynaphthalene with an excess of alkyl iodide in the pres 
ence of a base, e.g. potassium carbonate in an aprotic 
solvent to produce 1,5-dialkoxynaphthalene; (2) dealk 
ylating the thus-produced 1,5-dialkoxynaphthalene 
with an alkali metal alkanethiolate to remove selec 
tively one alkyl moiety; and (3) acidifying the alkoxide 
that is produced to form 5-alkoxy-1-naphthol. 
As can be understood from the above description, the 
processes of this invention permit the manufacture of 
doxorubicin less expensively and permit the effective 
preparation of derivatives thereof. 
DETAILED DESCRIPTION 
The synthesis of the intermediate, required for elabo 
ration of the A-ring, 3alpha,5alpha-dihydroxy-2alpha 
nitromethyl-5beta-(trimethylsilylethynyl)cyclohexane 
beta-carboxylate acetonide is shown in charts i and 2. 
It has been found that a 58 percent overall yield of 
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl)cy 
clohex-1-ene-1-carboxylate can be obtained by keeping 
the reaction mixture cold during esterification with 
diazomethane and removing any ethanol and water 
present in the esterification reaction mixture by azeo 
tropic distillation with benzene; quickly reacting to the 
thus-produced methyl ester with added cerium dichlo 
ride trimethylsilyl-acetylene at a low temperature to 
prevent formation of a lactone; forming the epoxide by 
oxidation with tert-butyl hydroperoxide in a fluxing 
benzene solution in the presence of molybdenum hex 
acarbonyl catalyst and isolating the thus-produced ep 
oxide and opening the thus-formed epoxide ring with 
1,8-diazabicyclo-5.4.0-undec-7-ene. Without the re 
cited precautions and using completely anhydrous ce 
rium dichloride, the yield from m-anisic acid is less than 
10 percent. 
Methyl 3alpha,5alpha-dihydroxy-2alpha-nitrometh 
yl-5beta-(trimethylsilylethynyl)-cyclohexane-1beta-car 
boxylate was obtained from methyl cis 
CHART 1 
HOOC C OMe 
(1) Li/NH3 
(2) NHC 
(3) H3O+ 
HOOC aO 
O 85%-90% 
just 
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4. 
-continued 
MeOOC aO 
: Cl2CeCeCSi(CH3)3/THF (2) NHC 
MeOOC CESiMe3 
OH (100%) 
o 
MeOOC CeCSiMe3 
OH 
(77%) 
CHART 2. 
MeOOC CeCSiMe3 
OH 
(70%) 
O 
puche 
MeOOC CECSiMe3 
OH 
(93%) 
o 
MeNO2/DBU/DMSO 
MeOOC CECSiMe3 
oH 
^ (40%) 
No oth 
pyridinium tosylate 
MeOOC CeCSiMe3 
o 
N (89%) 
2,3-epoxy-5-hydroxy-5-(trimethylsilylethynyl) cy 
clohexane-1-carboxylate by reaction with nitromethane 
in the presence of 1,8-diazabicyclo[5.4.0-undec-7-ene in 
an aprotic solvent that can serve as a hydrogen bond 
acceptor. Alternatively, methyl 3alpha,5alpha-dihy 
droxy-2alpha-nitromethyl-5beta-(trimethylsilylethynyl) 
cyclohexane-1betacarboxylate was obtained from 
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl)cy 
clohex-1-ene-1-carboxylate-and nitromethane in the 
presence of 1,8-diazabicyclo-5.4.0-undec-7-ene or so 
dium hydride in an aprotic solvent. 
The aprotic solvent used for the nitromethylation 
reaction may be selected from the following: hexame 
Se: CH2/ 
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thylphosphoramide, dimethyl sulfoxide and NN'- 
dimethyl-NN'-propylene urea. The preferred aprotic 
solvent is dimethyl sulfoxide. Nitromethane also adds to 
the 3,5-di-(terbutyldinnethylsilyl) ether of the diol. 
The nitromethylation is conveniently carried out at 
ambient temperature for a time necessary to complete 
the reaction. The required time is of the order of 12 to 
24 hours. If the reaction becomes exothermic, cooling 
to 15 to 25 degrees centigrade is preferred. 
An acetonide is formed from 3alpha,5alpha-dihy 
droxy-5beta-(trimethylsilylethynyl)-2alpha-nitrome 
thylcyclohexane-libeta-carboxylate by treatment with 
an acetonide-forming reagent. Representative aceto 
nide-forming agents include, but are not limited to, 
2-methoxypropene. Preferably, the acetonide-forming 
reagent is 2-methoxypropene. - 
The acetonide-forming reaction is carried out in the 
presence of a catalyst, such as pyridinium tosylate or 
n-toluenesulfonic acid. A preferred catalyst is pyridin 
ium tosylate. 
An inert solvent is used for the reaction. Benzene, 
heptane, toluene are representative of solvents suitable 
for the reaction. When benzene is used as the solvent, 
the reaction goes to completion within a few minutes' 
heating under reflux. Conditions appropriate for other 
solvents can be determined by routine experimentation. 
The synthesis of a representative 1,4-dihydro-4,4,5- 
trimethoxy-1-oxo-naphthalene is shown in Chart 3. The 
initial steps of the synthesis include alkylation of both 
hydroxyl groups of 1,5-dihydroxynaphthalene, fol 
lowed by selective removal 
CHART 3 
OH 
HO 
scover 
OMe 
OMe 
(1) NaSEt/DMSO 
(2) H+ 
OH 
OMe 
notococo 
O 
6 
-continued 
CHART 3 
O 
MeO OMe 
MeO 
of only one alkyl to give 5-alkoxy-1-naphthol. The alkyl 
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moiety can be selected from primary alkyls of 1-6 car 
bon atoms, such as methyl, ethyl and n-propyl. The 
alkyl iodide is used in an amount in excess of that, re 
quired to alkylate both hydroxyl groups. Preferably, a 
molar ratio in the range of 4:1 to 2.5:1 of alkyl iodide to 
1,5-dihydroxynaphthalene, is used. Most preferably, the 
ratio is about 3.5:1. 
The etherification reaction is conducted in the pres 
ence of a base, which is normally selected from organic 
and inorganic bases. Representative bases include, but 
are not limited to, sodium carbonate, potassium carbon 
ate, sodium hydroxide, potassium hydroxide, pyridine, 
triethylamine. A preferred base is potassium carbonate. 
The amount of base employed should be in the range of 
3.5 moles to 4.5 moles, per mole of 1,5-dihydroxynaph 
thalene. 
The aprotic solvent can be selected from acetone, 
methylethyl ketone, methylisobutyl ketone, tetrahydro 
furan, acetonitrile, dimethyl sulfoxide. Preferably, the 
solvent is acetone. 
The alkali metal alkanethiolate, used for removing 
one alkyl group from the intermediate dialkoxy com 
pound can be selected from sodium and potassium al 
kanethiolates, having 1-6 carbon atoms in the alkane 
moiety. Preferably, the alkali metal alkanethiolate is 
sodium methanethiolate or ethanethiolate. The resulting 
alkali metal alkoxide can be acidified with any mineral 
acid, of which sulfuric acid, hydrochloric acid and 
phosphoric acid are representative. 
The 5-alkoxy-1-napthol produced in this way can be 
converted, for example, to a corresponding juglone 
alkyl ether 4-ethylene ketal by reaction with ethylene 
glycol and thallium trinitrate or lodobenzediacetate in 
trimethyl orthoformate. A preferred ketal for down 
stream synthesis is 1,4-dihydro-4,4-ethylenedioxy-5- 
methoxy-1-oxonaphthalene, produced from 5-methoxy 
1-naphthol and ethylene glycol under the conditions 
stated. 
A most preferred product for downstream synthesis 
is 1,4-dihydro-4,4,5-trimethoxy-i-oxonaphthalene. This 
is preferably produced from 5-methoxy-1-naphthol by 
reaction with methanol and iodobenzene diacetate in 
trimethyl orthoformate. It will be understood that alka 
nols of 2-3 carbon atoms can be used to produce higher 
ketals by a similar process. 
The synthesis of daunomycinone from methyl 3al 
pha,5alpha-dihydroxy-2alpha-nitromethyl-5beta(trime 
thylsilylethynyl)cyclohexane-1beta carboxylate aceto 
nide and a representative 1,4-dihydro-44-5-trimethoxy 
1-oxonaphthalene is shown in Chart 4. Condensation to 
the 1-oxotetrahydronaphthalene is carried out in an 
aprotic solvent. The aprotic solvent may be selected 
from dimethyl sulfoxide, hexamethylphosphoramide 
and acetonitrile. Acetonitrile is preferred. The reaction 
is carried out at ambient temperature. Conversion to a 
representative intermediate, 3-(2beta-carbomethox 
ybeta-ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)- 
5,200,513 
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cyclohexanyl-1-yl-nitromethyl-4,4,5-trimethoxy-1- 
oxo-1,2,3,4-tetrahydronaphthalene is complete within 
4-6 days. 
The thus-produced 1-oxotetrahydronaphthalene is 
preferably cyclized with an alkali metal alkoxide of 1-6 
carbon atoms. Suitable alkoxides can be prepared from 
alkanols of 1-6 carbon atoms, as above, and an alkali 
metal hydride. Alkali metal hydrides include sodium hydride or potassium hydride, of which sodium hydride 
is preferred. Most preferably, the alkali metal alkoxide 
is sodium 
CHART 4. 
O 
MeOOC CECSiMe3 
-- O 
-- -X 
McO OMe oN o 
plume 
O 
(25%) 
MeO 
N 
OEC 
CECH 
H s O 
H o ->< 
OMe (MeO)2 NO2 juatovo 
OH 
(60%) 
(1) Ti(NO3)3 
(2) NaOMe/MeOH 
(3) TiCl3 
daunomycinone Ti complex 
methoxide. The cyclization is carried out in an inert 
solvent, such as benzene, hexane or toluene. 
A representative cyclic product of this condensation is 7alpha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl 
6-nitro-4,5-trimethoxy-5,5a, 6,6a,7,8,9,10,10a, 11 
decahydro-11-naphthacenone. 
The thus produced decahydro-1-naphthacenone 
loses methanol in the presence of an acidic catalyst to 
yield 7alpha,9alpha-(di-O-isopropylidenyl)-4,5-dime 
thoxy-9beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8, 
9,10,10a, 11-octahydro-11-naphthacenone. Possible cat 
alysts include sulfonic acids e.g. methanesulfonic acid; 
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pyridinium p-toluenesulfonate is preferred. A variety of 
aprotic solvents e.g. aromatic hydrocarbons, tetrahy 
drofuran, methylene chloride may be used; methylene 
chloride is preferred. 
The thus produced octahydro-11-naphthacenone was 
then oxidized to 7alpha,9alpha- (di-O-isopropylidenyl)- 
9beta-ethynyl-11-hydroxy-4-methoxy-7,8,9,10-tetrahy 
dro-5,12-naphthacenedione. Oxidizing agents include 
cerium ammonium nitrate (CAN) and thallium trinitrate 
(TTN); solvents include methanol, acetone and acetoni 
trile. The preferred conditions are CAN in acetone with 
dichlorodicyanobenzoquinone (DDQ) added in cata 
lytic amount. The thus produced 5,-12-naphthacened 
ione is then hydrolysed with acid in the presence of 
mercuric oxide to give 6-dexosy-6-nitrodauomycinone. 
The 6-nitro compound can then be reduced to 6 
desoxy-6-aminodaunomycinone from which 
daunomycinone and a variety of mycinones can be 
produced. These mycinones can be coupled by known 
methods to daunosamine to produce doxorubicin and its 
corresponding derivatives. 
In one embodiment, the aprotic solvent for condens 
ing the acetonide with 1,4-dihydro-4,4,5-trimethoxy-1- 
oxonaphthalene is acetonitrile; the thus-produced 1 
oxotetrahydronaphthalene is cyclized with sodium 
methoxide; the thus-produced decahydro-11-naph 
thacenone is converted to the octahydro-11-naphthace 
none in an acidic medium; the thus-produced octahy 
dro-11-naphthacenone is oxidized to the tetrahydro 
5,12-naphthacenedione with the thusproduced tetrahy 
dro-5,12-naphthacenedione being converted to 6 
desoxy-6-nitrodaunomycinone by hydrolysis and from 
this compound into daunomycinone and 6 to 8 
daunomycinones in which the substituent at C6 has been 
changed. 
In a further embodiment, the aprotic solvent for con 
densing the acetonide with 1,4-dihydro-4,4,5-trime 
thoxy-1-oxonaphthalene is acetonitrile; the thus-pro 
duced 1-oxotetrahydronaphthalene is cyclized with 
sodium methoxide; the thus-produced decahydro-11 
naphthacenone is converted to 9beta-acetyl-4,5-dime 
thoxy-6-nitro-7alpha,9alpha,12-trihydroxy 
6,6a,7,8,9,10,10a, 11-octahydro-11-napthacenone by hy 
drolysis with acid in the presence of mercuric oxide in 
an acidic medium; the thus-produced 9-beta 
acetylocatahydro-11-naphthacenone is oxidized to 7al 
pha,9-alpha-dihydroxy-4-methoxy-6-nitro 
6,6a,7,8,9,10,10a, 11-octahydro-5,11,12-naphthacenetr 
ione with thallium nitrate and the produced octahydro 
5,11,12-naphthacenetrione is converted to daunomyci 
Os. 
In a preferred embodiment, 6-desoxy-6- 
nitrodaunomycinone was converted into 6-desoxy-6- 
aminodaunamycinone by reduction with SnCl2.H2O in 
methanol in the presence of sodium on acetate at room 
temperature and the lenco product reoxidized with 
cerium ammonium nitrate. 
The amino daunomycinone has been converted into 
its diazonium compound with its amyl nitrite in dimeth 
oxyethane and then acid and finally mercuric oxide was 
added to form daunomycinone. A variety of other 6 
desoxy-6-substituted daunomycinones are available 
from the diazonium compound. 
EXAMPLES 
Without further elaboration it is believed that one 
skilled in the art can, using the preceding description, 
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utilize the present invention to its fullest extent. The 
following preferred specific embodiments are, there 
fore, to be construed as merely illustrative and not limi 
tative of the remainder of the disclosure in any way 
whatsoever. 
In the following examples, the temperatures are set 
forth uncorrected in degrees centigrade. Unless other 
wise indicated, all parts and percentages are by weight. 
Materials and Methods 
1H NMR spectra were recorded on a Varian EM-390 (90 MHx), a Varian VXR-200 (200MHx) or a Nicolet 
1180 WB (360 MHz) spectrometer. Data are reported as 
chemical shifts in parts per million referenced to trime 
thylsilane internal standard (0 ppm) or to the residual 
chloroform peak of deuteriochloroform (7.26 ppm). 
Multiplicity, number of protons and coupling constants 
are reported. Couplings and/or coupling constants 
were determined using the COSY technique or by pro 
ton irradiation experiments. 
13C NMR spectra were obtained on a Varian 
VXR200 (50.4 MHz) spectrometer. Chemical shifts are 
referenced to the center peak of the residual chloroform 
triplet (77.0 ppm). 
Ultraviolet spectra were obtained on a Hewlett-Pac 
kard 8450 UV-Vis spectrophotometer. 
Infrared absorption spectra were recorded on a Per 
kin-Elmer Model 283 or an Analect RFX-30 spectro 
photometer and are referenced to polystyrene (1601 
cm). 
Elemental analyses were carried out by Desert Ana 
lytics (Tuscon, Ariz.). - , 
Mass spectra were provided by the Midwest Center 
for Mass Spectrometry, University of Nebraska-Lin 
coln. - 
Melting points were determined in open-end capil 
lary tubes on a Mel-Temp apparatus. 
Column chromatography was carried out on E. 
Merck silica gel 60 (Flash, 40-230 mesh) and all thin 
layer chromatography (TLC) was carried out on com 
mercial silica gel plates (Analtech Silica HLF 250 m or 
Merck Silica gel 60F 254). 
High performance liquid chromatography (HPLC) 
was performed on a Waters Associates Model 600E 
chromatography apparatus, equipped with a Waters 
Associates Model R403 Differential Refractometer, 
using normal-phase silica gel columns. 
Solvents were distilled before use over an appropriate 
drying agent under a nitrogen atmosphere. All reactions 
requiring anhydrous conditions were done under nitro 
using a Buchi rotary evaporator, then by evacuation at 
about 0.10 mm Hg at room temperature. 
EXAMPLE 1 
5-Oxocyclohex-2-ene-1-carboxylic Acid 
The procedure of Biffin et al., Aust. J. Chem, vol. 25 
(1972), page 1329, was used. 
To a stirred slurry of 30 g (0.21 mol) of m-anisic acid (3-methoxybenzoic acid) in 300 mL of liquid ammonia 
were slowly added small pieces of lithium (3.5 g, 0.5 
mol). Additional lithium (0.5g, 0.07 mol) was added to 
maintain the blue color of the solution. The mixture was 
stirred for 2 hours and then cautiously quenched with 
solid ammonium chloride (45 g, 0.84 mol). 
Ammonia was allowed to evaporate at room temper 
ature. The last traces of ammonia were removed by 
warming the mixture under aspirator pressure. The 
O 
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resulting residue was dissolved in 200 mL of ice water 
and acidified to pH 1 with conc HC. The resulting 
solution was extracted with four 100-mL portions of 
ethyl acetate. The combined ethyl acetate extracts were 
washed with one 50-mL portion of saturated sodium 
chloride solution, dried over sodium sulfate and evapo 
rated to dryness. Crude semi-crystalline acid (24.1 g) 
was washed with a small amount of cold ether to yield 
5-oxocyclohex-2-ene-1-carboxylic acid, off-white crys 
tals, mp 98-101 degrees centigrade, lit (Biffin et al., 
supra, 98 to 99 degrees centigrade) yield 80 to 90 per 
Cent. 
H NMR (CDCl3): delta values 10.0 (s, 1H, COOH), 
5.9 (m, 2H, HC-CH), 3.5 (m, 1H, CHCOO), 2.8 (m, 
2H, C=CCH2), 2.5 (m, 2H, CH2). 
EXAMPLE 2 
Methyl 5-Oxocyclohex-2-ene-1-carboxylate 
A solution of 0.7M diazomethane in ether was slowly 
added to a solution of 6.0 g (42.8 mmol) of 5-oxocy 
clohex-2-ene-1-carboxylic acid in 100 mL of ether at 0 
degrees centigrade, with swirling. The addition of di 
azomethane was continued until the bubbling ceased 
and a yellow color persisted. The solution was treated 
with a rapid stream of nitrogen until the yellow color 
was discharged. The solvent was removed by evapora 
tion. Benzene (100 mL) was added and evaporated at 
room temperature using an aspirator. The residue was 
placed on a vacuum line for 2 hours to produce 6.5g (42.4 mmol, 99 percent) of methyl 5-oxocyclohex-2-ene 
1-carboxylate (oil). 
1NNMRCDCl3): delta values 5.9 (m, 2H, HC-CH), 
3.7 (s, 3H, COOMe), 3.5 (m, 1H, HCOO), 2.9 (m, 2H, 
C=CCH2), 2.7 (m, 2H, CH2). 
EXAMPLE 3 
Methyl 
cis-5-Hydroxy-5-(trimethylsilylethynyl)cyclohex 
2-ene-1-lcarboxylate 
A solution of n-butyllithium (2.5 M, 16.8 mL, 42.1 
mmol) was added dropwise, via a syringe, to a stirred 
solution of trimethylsilylacetylene (7 mL, 46.8 mmol) in 
120 mL of tetrahydrofuran (THF) at -78 degrees cen 
tigrade. The resulting slurry was stirred at -78 degrees 
centigrade for 15 minutes and transferred via a cannula 
to slurry of 13.45 g (54.6 mmol) of cerium trichloride in 
80 mL of THF at -78 degrees centigrade. The cerium 
so chloride had been obtained by drying cerium trichlo 
gen in flame-dryed flasks. Solvents were evaporated N 
55 
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ride heptahydrate (20.4 g, 54.6 mmol) at 140 to 160 
degrees centigrade/0.1 mm Hg for 2 hours. Nitrogen 
was admitted to the cooled flask and 80 mL of dry THF 
was added to the resulting slurry, which was stirred 
overnight under nitrogen. 
After the addition was complete (45 minutes), the 
resulting mixture was stirred for 1 hour at -78 degrees 
centigrade. The organocerium reagent, cerium dichlo 
ride trimethylsilylacetylide, was transferred over 45 
minutes into a solution of 6.36 g (41.3 mmol) of methyl 
5-oxocyclohex-2-ene-1-carboxylate in 80 mL of THF at 
-78 degrees centigrade. The resulting mixture was 
stirred for 1 hour more at -78 degrees centigrade and 
the reaction mixture was poured without warming into 
400 mL of 10 percent ammonium chloride solution at 0 
degrees centigrade. The resulting mixture was extracted 
with four 150-mL portions of ether. The combined 
organic extracts were washed with 200 mL of saturated 
5,200,513 
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aqueous sodium chloride solution and dried over so 
dium sulfate. Evaporation of the solvent yielded 10.04g (41.1 mmol, 99.5 percent) of methyl cis-5-hydroxy-5- (trimethylsilylethynyl)cyclohex-2-ene-1-carboxylate, 
an oil. 
IR(CH2Cl2): 3585 (COH), (COOCH3), 1653 (CEC) cm-l. 
NRMCDCl3): delta values 5.9-5.7 (n, 2H, 
CH=CH), 3.7 (s, 3H, COOCH3), 3.3 (m, 1H, CHCOO), 
2.6 (s, H, OH), 2.5 (dd, 1H, C-CCH2), 2.4 (dd, H, 
C-CCH2), 2.2 (m, 2H, CH2), 0.2 (s, 9H, Si(CH3)3). 
13C NMR CDCl3): delta values 174.0, 125.3, 1234, 
108.2, 87.4, 65.7, 51.9, 41.2, 39.1, 37.6. 
MS, m/e (relative intensity): 252.21166 Mt (0.72), 
237,0949 M-CH3+ (29), 140,0657 (61). HRMS calcd 
for Cl3H20O3Si: 252.1181. 
Anal. Calcd for C13H20O3Si: C, 61.86, H, 7.99. 
Found: C, 62.10, H, 8.13, 
EXAMPLE 4 
Methyl 
cis-(2,3-Epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cy 
clohexane-1-carboxylate 
A solution of tert-butyl hydroperoxide (4.1 M, 0.85 
mL, 3.4 mmol) in isooctane was added to a stirred mix 
ture of molybdenum hexacarbonyl (10 mg, 0.07 mmol) 
and 0.1753 g (0.6946 mmol) of methyl cis-5-hydroxy-5- (trimethylsilylethynyl)cyclohex-2-ene-1-carboxylate in 
10 mL of benzene. The mixture was then heated under 
reflux for 2 hours. The mixture cooled and was washed 
with three 10-mL portions of water. The combined 
aqueous layers were extracted with three 5-mL portions 
of methylene chloride and dried over sodium sulfate. 
Evaporation of the solvent gave 0.1805 g (97 percent) of 
an oil. Flash chromatography of the oil (4:1 hexanes 
Methyl acetate v?v) gave crystalline methyl cis-(2,3- 
epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cyclohex 
ane-1-carboxylate (0:131 g, 70 percent), mp. 74.1 to 74.6 
degrees centigrade. 
IR(KBr): 3360 (OH), 2160 (C=C), 1732 (C=O), 
1260, 845 cm-l. 
1H NMR CDCl3) 3.8 (s, 3H, COOCH3), 3.5 (m, H, 
CHCOO), 3.3 (m, 2H, HCOCH), 2.4 (dd, 1H, CH2), 2.3 
(s, H, OH), 2.0 (d, 1, CH2), 1.85 (m, 2H, CH2), 0.17 
(s, 9H, CsCSi(CH3)3). 
13C NMR CDCl3) 172.45 (COO), 107.43 (SiCEC), 
89.47 (CsC), 66.26, 52.2, 51.80, 50.71, 40.92, 38.26, 
31.03, 0.20 (Si(CH3)3). 
MS m/r (relative intensity): 253.0897 (21.8) M 
CH3+, 236,0871 (38.2) M-CH3OH)+, 191.0035 (19.3), 
159,0715 (16.6). Calcd for C13H20OSi: 253.0896. 
Anal. Calcd for C13H2O4Si: C, 58,18, H, 7.51. Found: 
C, 58.09, H, 7.65. 
2160 (CEC), 1721 
EXAMPLES 
Methyl 
cis-3,5-Dihydroxy-5-(trimethylsilylethynyl)cyclohex 
1-ene-1-carboxylate. 
A solution of 92.8 mg (0.345 mmol) of methyl cis-(2,3- 
epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cyclohex 
ane-1-carboxylate and 52.5 mg (0.345 mmol) of 1,8- 
diazabicylo-5.4.0-undec-7-ene in 10 mL of methylene 
chloride was stirred for 2 hours at room temperature. 
The solvent was removed by evaporation and the resi 
due was dissolved in a minimum amount of methylene 
chloride and filtered through a plug of flash silica gel 
. (1:1 hexanes/ethyl acetate v/v). Evaporation of the 
O 
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solvent yielded methyl cis-3,5-dihydroxy-5-(trimethyl 
12 
silylethynyl)cyclohex-1-ene-1-carboxylate, a colorless 
oil, which crystallized on standing, mp 89.8 to 90.8 
degrees centigrade. 
IR (CH2Cl2): 3310 (OH, 2658 (C-C), 
(COOCH3), 1653 cm-1. 
iH NMR CDCl3): delta values 7.1 (s, 1H, CCH), 4.4 
(m, all couplings less than 2 Hz, 1H, CCHOH)), 3.8 (s, 
3H, COOCH3), 3.0-3.4 (m, H, OH), 2.9-2.8 (dd, 2H, 
CH2), 2.6 (s, 1H, OH), 2.5-2.2 (dd, 2H, CH2), 0.17 (s, 
9H, C-CSi(CH3)3). 
1H NMR (D6DMSO): delta values 7.1 (s, 1H, 
C=CH), 6.2 (2,1H, OH), 5.6 (d, 1H, OH), 4.7 (bs, 1H, 
CCHOH)), 4.0 (s, 3H, COOCH3), 3.0 (d, Jai 7 Hz, 1H, 
C=CCH equatorial), 2.6 (d, J =17 Hz, 1H, C=CCH 
axial), 2.5 (n, 1H, (HOCCH axial), 1.9 (dd, J-10, 10 
Hz, 1H (HO)CCH axial). 
13C NMR CDCl3): 167.20 (C=O), 138.88, 127.60, 
108.0, 88.52, 66.04, 61.62, 51.92, 41.74, 38.87, 0.228. 
Anal. Calcd for C13H20O4Si: C, 58.18; H, 7.51. 
Found: C, 58.24; H, 7.65. 
EXAMPLE 6 
Addition of Nitromethane to Methyl 
cis-3,5-Dihydroxy-5-(trimethylsilylethynyl)cyclohex 
1-ene-1-carboxylate 
(i) Methyl cis-3,5-dihydroxy-5-trimethylsilylethynyl 
cyclohex-1-ene-1-carboxylate (5.91 g, 22.0 mmol) was 
added in one portion to a mixture of nitromethane (12.2 
g, 44.0 mmol) and DBU (6.7g, 22.0 mmol) in 30 mL of 
dimethyl sulfoxide (DMSO). The mixture was stirred at 
room temperature for 15 hours and then neutralized to 
pH 6 with about 20 mL of 6 M HCl. 
The resulting mixture was extracted with four 100 
mL portions of ethyl acetate. The organic phase was 
washed with 30 mL of saturated aqueous sodium chlo 
ride solution and dried over sodium sulfate. Evapora 
tion of the solvent gave a crude oil product (10.0 g), 
which contained some DMSO. m 
Flash chromatography in ethyl acetate/hexanes (3:7 
v/v) gave methyl 3alpha,5alpha-dihydroxy-5beta 
(trimethylsilylethynyl)-2alpha-nitromethylecyclohex 
ane-1-beta-1-carboxylate (trans isomer, 0.8321g, 2.5 
mmol, 11.5 percent); methyl 3alpha,5alpha-dihydroxy 
5beta-trimethylsilylethynyl-2beta-nitromethylcy 
clohexane-2beta-carboxylate (the cis isomer, 1.95 g, 5.9 
mmol, 26.9 percent); methyl 3alpha, 5alpha-dihydroxy 
5beta-ethynyl-2alpha-nitromethylcyclohexane-1beta 
carboxylate (trans desilylated isomer, 1.52 g. 5.9 mmol, 
26.9 percent); methyl 3alpha,5alpha-dihydroxy-5beta 
ethynyl-2beta-nitromethylcyclohexane-1beta-carboxy 
late (cis desilylated isomer, 1.28, 5.0 mmol, 22 percent). 
The overall yield of nitro adducts was 88 percent. 
(ii) Nitromethane (8 mL, 112 mmol) was added to a 
slurry of sodium hydride (2.4g, 56 mmol, 50 percent in 
mineral oil) in 50 mL of dry DMSO. The mixture was 
cooled as necessary to maintain an internal temperature 
of 20 degrees centigrade and stirred slowly for 1 hour. 
Methyl c is-3,5-dihydroxy-5-(trimethylsilylethynyl)- 
cylohex-1-ene-1-carboxylate (3.0 g. 11.2 mmol) was 
added in one portion and the mixture was stirred for 24 
hours at room temperature. To the resulting mixture 
was added 3 mL of conc HCl in ice. Additional HC1 
was added until the pH reached 7. The mixture was 
extracted with four 150-mL portions of ether, washed 
with 100 mL of saturated aqueous sodium chloride 
solution, dried over sodium sulfate and evaporated to 
1721 
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give 3.39 g of residue, which contained some DMSO 
(TLC). 
Flash chromatography in ethyl acetate/hexanes (3:7 
v/v) gave 2.12 g of product, characterized as a mixture 
of diastereomeric methyl 3,5-dihydroxy-5-(trimethyl 
silylethynyl)-2-nitromethylcyclohexane-1-beta-car 
boxylates. 
Trans isomer (1.021 g, 25.8 percent), methyl 3alpha, 
5alpha-dihydroxy-5beta-(trimethylsilylethynyl)- 2al 
pha-nitromethylcyclohexane-1betacarboxylate: 
IR (CH2Cl2): 3421, 2958, 2161, 1737, 1558 cm-1. 
1H NMR CDCl3): delta values 4.7-4.6 (dd, 1H, 
CH2NO2), 4.0-4.1 (m, 1H, CHOH), 3.8 (bs, 2H, OH), 
3.7 (s, 3H, COOCH3), 2.8-2.9 (ddd, J =4, 12, 12 Hz, 
CHCOOCH3) 2.5-2.6 (m, 1H, CHCH2NO2), 2.3-2.4 (m, 2H, CH2 equatorial), 2.0 (dd, J =12, 12 Hz, 1H, 
CH2 axial), 1.9 (dd, J =12, 3 Hz, lh, CH2 axial), 0.1 (s, 
9H, Si(CH3)3). 
13C NMR (CDCl3): delta values 173, 128, 106, 87,75, 
67.1, 66.8, 52, 41.5, 41.2, 36.7, 0.3. 
Cis isomer (1.101 g, 19.8 percent), methyl 3alpha,5al 
pha-dihydroxy-5beta-(trimethylsilylethynyl)-2beta 
nitromethylcyclohexane-1betacarboxylate: 
IR (CH2Cl2) 3423, 2956,2160, 1739, 1556 cm-1. 
1H NMR CDCl3): delta values 4.6 (dd, 1H, 
CH2NO2), 4.1 (m, 1H, CHOH), 3.7 (s, 3H, COOCH3), 
2.9 (bs, 2H, OH), 2.0-2.2 (nc, 4H, CH2), 0.2 (s, 9H, 
Si(CH3)3). 
13C NMR: delta values 173, 128, 106, 89, 74, 67.7, 
67.1, 52, 41, 37, 30, 0.2. 
Anal. Calcd for C14H22O6NSi: C, 51.20, H. 6.75, N, 
4.26. Found: C, 51.20; H, 7.19: N, 4.17. 
EXAMPLE 7 
Addition of Nitromethane to Methyl 
cis-(2,3-Epoxy-5-hydroxy)-5-(trimethylsilylethynyl)cy 
clohexane-1-carboxylate 
Nitromethane (4.2g, 68 mmol) was added to a solu 
tion of 50 mL of DMSO and 5.2 g (34 mmol) of DBU 
in 50 mL of DMSO. The mixture was stirred for 5 
minutes, after which 1.8 g (6.8 mmol) of solid methyl 
cis-2,3-epoxy-5-hydroxy-5-(trimethylsilylethynyl)cy 
clohexane-1-carboxylate was added in one portion. The 
reaction was followed by TLC, using 1:2 v/v ethyl 
acetate/hexanes as eluant. After 2 hours, all of the epox 
ide had been consumed and a new spot, corresponding 
to diol appeared. After 16 hours, TLC showed that four 
new products and no starting materials or diol was 
present. 
The reaction mixture was poured into 100 mL of cold 
5 percent HCl solution and extracted with four 50-mL 
portions of water and with 100-mL of saturated aqueous 
NaCl solution and dried over sodium sulfate. The ether 
was evaporated to yield 0.66 g of an oil, which was 
separated by flash chromatography (1:2 v/v ethyl 
acetate/hexanes) to yield methyl 3alpha, 5alpha-dihy 
droxy-5beta-(trimethylsilylethynyl)-2 alpha-nitrome 
thylcyclohexane-1beta-carboxylate (0.28 g, 12.5 per 
cent, trans nitro diol) and methyl 3alpha,5alpha-dihy droxy-5beta-(trimethylsilylethynyl)-2beta-nitromethyl 
cyclohexane-1beta-carboxylate (0.31 g, 13.8 percent, cis 
nitro diol). 
The aqueous phase was reextracted with methylene 
chloride and dried over sodium sulfate. Evaporation of 
solvent gave 0.52g of an oil, separated by flash chroma 
tography (1:l v/v ethyl acetate/hexanes) into two desilylated nitroadducts, methyl 3alpha,5alpha-dihy 
droxy-5beta-ethynyl-2alphanitromethylcyclohexane 
O 
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1beta-carboxylate (0.25 g, 12.4 percent, trans desilylated 
isomer) and methyl 3alpha, 5alpha-dihydroxy-5beta 
ethynyl-2beta-nitromethylcyclohexane-2beta-carboxy 
late (0.19 g, 9.4 percent, cis desilylated isomer). 
EXAMPLE 8 
Acetonide of Methyl 3alpha,5alpha-Dihydroxy-5 
beta-(trimethylsilylethynyl)-2alpha-nitromethylcy 
clohexane-1beta-carboxyate 
A mixture of 2-methoxypropene (260 microL, 3.6 
mmol), trans nitro diol (methyl 3alpha,5alphadihy 
droxy- 5beta-(trimethylsilylethynyl)-2alpha-nitrome 
thylcyclohexane-1beta-carboxylate, 1.2 g, 3.6 mmol) 
and pyridinium tosylate (10 mg, 0.036 mmol) in 100 mL 
of benzene was stirred for at room temperature for 15 
minutes. After 260 microL (3.6 mmol) of additional 
2-methoxypropene was added, the resulting mixture 
was heated under reflux for 5 minutes. The resulting 
solution was cooled and washed with 30 mL of satu 
rated aqueous sodium bicarbonate solution with 30 mL. 
of saturated aqueous sodium chloride solution and dried 
over sodium sulfate. Evaporation of solvent yielded 
1.22 g (3.22 mmol, 89 percent) of acetonide as an oil. 
R (neat ATR): 2990, 2164, 1735, 1556 cm-l. 
1H NMR CDCl3) delta values 4.6-4.5 (dd, 1H, 
CHNO2), 4.44.35 (dd, 1H, CHNO2), 4.25-4.3 (m, 1H, 
CHOC), 3.7 (s, 3H, COOCH3), 3.0 (ddd, J =3, 4, 15 Hz, 
1H, CH equatorial), 2.85 (ddd, J =5, 12, 12 Hz, 1H, 
CHCOOCH2), 2.6 (m, 1H, CHCH2NO2), 2.4 (ddd, J 
=3, 5, 15 Hz, 1H, CH equatorial), 1.8 (m, 2H, CH axi 
als), 1.6 (s, 3H, CH3), 1.4 (s, 3H, CH3), 0.16 (s, 9H, 
Si(CH3)3). 
13C NMR CDCl3): delta values 1736, 106.3, 97.9, 
88.5, 75.2, 66.3, 65.4, 52.0, 41.8, 41.5, 38.7, 33.0, 31.4, 
30.3, 0.3. 
HRMS, m/e (relative intensity): 354.1366 (M-CH3)+ 
(11 3), 294.1158 (M-OC3 H6+ (5.4), 264. 1184 (294 
NO2+ (46.5), 73.0472 TMSi)+ (100); calcd for 
C6H24NO 6Si 354.1373. 
EXAMPLE 9 
Oxidation of 1-hydroxy-5-methoxy-naphthalene to 
1,4-dihydro-4,4,5-trimethoxy-1-oxonaphthalene by 
Iodobenzene Diacetate 
A solution of 15.5g (48 mmol) of iodobenzene diace 
tate and 22g of NaHC3 in 100 mL of methanol/- 
trimethyl orthoformate (1/1) was stirred at room tem 
perature for 30 minutes. To this mixture a solution of 
3.74g of 1-hydroxy-5-methoxynaphthalene (21.5 mmol) 
in 250 mL of methanol was added dropwise. The color 
of the mixture changed from orange to greenish yellow 
over 2 hours at room temperature. 
Ether (150 mL) was added to the mixture, and then 
sat. NaHCO3 (75 mL). The aqueous washings were 
back extracted with ether (75 mLX3). The combined 
ethereal extracts were washed with saturated aqueous 
sodium chloride solution and dried over sodium sulfate. 
The solution was evaporated to give 1,4-dihydro-4,4,5- 
trimethoxy-1-oxonaphthalene. 
Flash chromatography of this product with elation 
using EtOAc:Hex 1:1 yielded 3.70g (74 percent) of 
crystals of 1,4-dihydro-4,4,5-trimethoxy-1-oxonaphtha 
lene, mp. 62-63 degrees centigrade. 
H NMR (CDCl3): delta values 7.7 (d, 1H, aromatic), 
7.52 (t, 1H, aromatic), 7.16 (d, 1H, aromatic), 6.80 (m, 
5,200,513 
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2H, HC-CH), 3.92 (s, 3H,OCH3), 3.14 (s, 6H, 
(OCH3)2) (2 OCH3). 
UV (MeOH): maximum wavelength; 222 nm. 
IR (neat): 1672, 1635, 1589, 1580, 1300, 1178, 1068, 
1031 cm-l. 
EXAMPLE 10 
3-(2beta-Carbomethoxy-4-beta-ethynyl-4-alpha-6alpha (di-O-isopropylidenyl)-cyclohexanyl-1-yl)nitromethyl 
4,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene 
A solution of 0.904 g (3.0 mmol) of trans nitroaceto 
nide (acetonide of methyl 3alpha, 5alpha-dihydroxy 5beta-(trimethylsilylethynyl)-2alpha-nitromethylcy 
clohexane-1beta-carboxylate), 1.34 g (5.7 mmol) of 1.4- 
dihydro-4,4,5-trimethoxy-1-oxonaphthalene and 750 
microL (5 mmol) of DBU in 0.5 mL of acetonitrile was 
stirred for 5 days at room temperature. Methylene chlo 
ride (5 mL) was added to the mixture and the solution 
was chromatographed on a column packed with 150 g 
of silica gel (5 cm column, 30:70 v/v ethyl acetate/hex 
anes slurry). The material on the column was eluted 
with 400 mL of 30:70 v/v ethyl acetate/hexanes. After 
the nitro acetonide was eluted, as followed by TLC (iodine development), the chromatographic separation 
was continued with 1000 mL of 50:50 v/v ethyl aceta 
te/hexanes. 
Evaporation of the solvent from the various fractions 
gave recovered nitro acetonide (0.66 g, 2.2 mmol), re 
covered dimethyl ketal (1.03 g, 4.4 mmol) and product, 3-((2beta-carbomethoxy-4-beta-ethynyl-4-alpha,6alpha (di-O-isopropylidenyl)cyclohexanyl-1-yl)-nitromethyl 
4,4,5-trimethoxy-1-oxo-1,2,3,4-tetrahydronaphthalene 
(0.274 g, 0.51 mmol, 62 percent based on recovered 
acetonide) as an oily mixture of diasteromers. 
IR (ATR thin film): 1733 (COOMe), 1686 (C=O), 
1588, 1579 (NO2) cm-1. 
1H NMR (CDCl3): delta values 7.6 (d, 1H, Ar), 7.4 
(dd, 1H, Ar), 7.1 (d, 1H, Ar), 5.3-5.0 (d, 1H, CHNO2), 
44-4.0 (m, 1H, CHOC), 3.7 (s, 3H, Ar0CH3), 3.5 (s, 
3H, COOCH3), 3.3-2.8 (complex group of overlapping 
protons, 10H), including (COCH3 ketal, 3.2, 3H, and 
3.1, 3H), (O-CCH2, 2H), and (CHCOOCH3, 1H), 
(HCCHNO2, 1H)), 2.5 (s, 1H, C=CH), 2.5 (d, iH, 
CH2), 2.2 (d, 1H, CH2), 1.8 (d, 1H, NO2CHCH), 1.6-1.5 
(m, 2H, CH2, 1.5 (s, 3H, CCH3), 1.2 (s, 3H, CCH3). 
13C NMR (CDCl3): mixture of two distereomers, 
(195.4, 195.1), (174.3, 173.2), (157.6, 157.5), (134.3, 
134.0), (130.3, 1302), (125.3), (120.05, 1200), (117.2, 
117.15), (101.6, 101.6), (97.9, 97.7), (86.1, 85.10), (84.48, 
84.42), (72.6, 72.5), (66.0, 65.9) (64.5, 64.4), (55.9), (52.2, 
51.6), (50.56, 50.46), (50,4, 50.1), (43.443.1), (42.8, 42.7), (42.0, 40.7), (39.77, 39.70), (35.8, 35.6), (32.7, 32.6), (31.2, 
31.1), (30.05, 29.9). 
EXAMPLE 11 
9beta-Ethynyl-5,5-dimethoxy-12-hydroxy-7alpha, 
9alpha-di-O-isopropylidenyl)-4-methoxy-6-nitro-5, 
5a,6,6a,7,8,9,10,10a-decahydro-11-naphthacenone 
Sodium hydride (64 mg, 1.4 mmol) was added in one 
portion to a solution of 3-[(2beta-carbomethoxy-4-beta 
ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)cyclohex 
anyl-1-yl)-nitromethyl-4,4,5-trimethoxy-1-oxo-1,2,3,4- 
tetrahydronaphthalene (0.377 g, 0.7 mml) and methanol (80 drops) in 25 mL of toluene at 0 degrees centigrade. 
After 15 minutes' stirring, the cooling bath was re 
moved. The reaction mixture was stirred for an addi 
tional 4 hours at room temperature and then washed 
briefly with 10 mL of cold 5 percent HCl. The organic 
5 
O 
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phase was further washed with 5 mL of saturated aque 
ous sodium bicarbonate solution, with two 10-mL por 
tions of saturated aqueous sodium chloride solution and 
dried over sodium sulfate. The solvent was evaporated 
to give 0.372 g of crude oily product, which was flash 
chromatographed (30:70 v/v ethyl acetate/hexanes, 
then 50:50 ethyl acetate/hexanes) to yield 0.212 g (0.42 
mmol, 59.8 percent) of 9beta-ethynyl-5,5-dimethoxy-12 
hydroxy-7alpha,9alpha-(di-O-isopropylidenyl)-4- 
methoxy-6-nitro-5,5a,6,6a,7,8,9,10,10a, li-decahydro 
11-naphthacenone, white crystalline solid, mp 234 de 
grees centigrade (decomp). 
IR (ATR thin film): 3320 (C=C-OH), 2260 (CECH), 
1559 (NO2) cm-1. 
1H NMR (CDCl3): delta values 16.2 (s, 1H, 
C-COH), 7.8 (d, H, ArH), 7.1 (d, 1H, ArH), 5.2 (dd, 
J =1, 3 Hz, 1H, CHNO2), 4.6 (d, J =4.5 Hz, 1H, 
CHOC), 3.9 (s, 3H, ArOCH3), 3.9 (ddd, J = 4.5, 13, 13 
Hz, 1H, 0-CCH), 3.5 (d, J =4.5Hz, 1H, C=C-CHC 
HNO2), 3.4 (s, 3H, OCH3 ketal), 3.1 (ddd, 1H, CH2 
equatorial), 3.0 (s, 3H, OCH3 ketal), 2.9 (ddd, J =3, 3, 
13 Hz, 1H, CH2 equatorial), 2.5 (s, 1H, CsCH), 1.8 (d, 
J=12 Hz, 1H, NO2CHCHCO), 1.67 (d, 1H, CH2 axial), 
1.64 (s, 3H, OCCH3), 1.5 (dd, J =12, 12 Hz, 1H, CH2 
axial), 1.3 (s, 3H, OCCH3). 
13C NMR (CDCl3): HETCOR-DEPT 196.9 (C-O), 
172.6 (ArC=COH), 157.2 (ArC=COH), 133.0 (Ar), 
130.6 (ArH), 122.8 (Ar), 119.4 (ArH), 115.7 (ArH), 
101.6, 101.3, 98.4, 85.2 (CECH), 79.9, 72.1 (CHNO2), 
69.5 (CHOC), 66.3, 55.8 (ArOCH3), 52.5 (COCH3), 51.4 
(COCH3), 46.0 (NO2CCHCO), 44.8 (CHCNO), 402 
(CH2), 35.3 (CHC-O), 34.3 (CH2), 30.8 (OCCH3), 30.4 
(OCCH3). 
UV-Vis: maximum wavelengths: 346, 341,230 nm. 
EXAMPLE 12 
9beta-Acetyl-7alpha,9alpha, 12-trihydroxy-4,5-dime 
thoxy-6-nitro-6,6a,7,8,9,10,10a, 11-octahydro-1lnaph 
thacenone 
Sulfuric acid (1.5 mL, 3M) was added to a solution of 
212 mg (0.42 mmol) of 9beta-ethynyl-5,5-dimethoxy-12 
hydroxy-7alpha,9alpha-(di-O-isopropylidenyl)-4- 
methoxy-6-nitro-5,5a,6,6a,7,8,9, 10,10a,11-decahydro 
11-naphthacenone in 20 mL of THF. The solution im 
mediately turned a bright yellow color. To the resulting 
solution was added 24.5 mg (0.11 mmol) of HgO. The 
resulting mixture was stirred for 4 hours at room tem 
perature, cooled to 0 degrees centigrade and neutralized 
to pH 6 with 0.5g of potassium hydroxide in 3 mL of 
water. The mixture was poured into 20 mL of water and 
extracted with four 20-mL portions of ethyl acetate. 
The combined organic layers were washed with two 
20-mL portions of water and with 20 mL of saturated 
aqueous sodium chloride solution and dried over so 
dium sulfate. The solvent was removed by evaporation 
to yield 0.176 g (0.39 mmol, 93.2 percent) of 9beta-acet 
yl-7alpha,9alpha, 12-trihydroxy-4,5-dimethoxy-6-nitro 
6,6a,7,8,9,10,10a, 11-octahydro-11-naphthacenone, yel 
low solid. Product recrystallized from acetone gave fine 
yellow needle crystals, mp 186 degrees centigrade (de 
comp). 
65 
IR (ATR thin film): 3427 (OH), 1711 (C-O), 1628, 
1591, 1554 (NO2) cm1. 
H NMR (THF D4): delta values 14.3 (s, 0.5H, 
AroH), 8.0 (d, 1H, ArH), 7.5 (dd, 1H, ArH), 7.2 (d, 1H, 
ArH),m 6.4 (d, 1H, CHNO2), 5.5 (bs, 0.5H, OH), 5.0 (bs, 
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0.5H, OH), 4.6 (m, 1H, CHOH), 3.9 (s, 2H, ArCCH3 
D-ring), 3.7 (s, 3H, Ar0CH3 C-ring), 3.7 (ddd, 1H, 
COCH), 2.6 (ddd, H, CH2 equatorial), 2.5 (ddd, 1H, 
CH2 equatorial), 2.3 (s, 3H, COCH3), 1.8 (m, 1H, 
NO2CHCH), 1.8-1.7 (m, 2H, CH2 axials partly ob 
scured by THF peak). 
13C NMR (THF D4): delta values 211.3 (C-O), . 
206.7 (C=O), 160,0, 157.3, 128.5, 122.4, 117.6, 117.5, 
112.5, 112.4, 10.1, 81.9, 80.4, 69.87, 69.83, 62.7, 56.6, 
46.0, 39.1, 36.2, 35.9, 35.8. 
UV-Vis (MeOH) maximum wavelengths: 339, 321, 
262,220 nm. 
EXAMPLE 13 
9beta-Acetyl-7alpha,9alpha-dihydroxy-4-methoxy-6- 
nitro-5,6,6a,7,8,9,10,10a,11,12-decahydro-5,11-12-naph 
thacenetrione 
Thallium nitrate (55 mg, 0.11 mmol) was added to a 
solution 50 mg (0.11 mmol) of 9beta-acetyl-7alpha,9al pha,12-trihydroxy-4,5-dimethoxy-6-nitro-6,6a,7,8,9,10,- 
O 
15 
20 
10a, 11-octahydro-11-naphthacenone in 5 mL of acetone 
at 0 degrees centigrade. The mixture was brought to 
room temperature and stirred for 2 hours. Additional 
thallium trinitrate (11 mg, 0.02 mmol) was added and 
stirring was continued for 1 hour. The resulting solution 
was poured into 20 mL of water and extracted with 
three 25-mL portions of ethyl acetate. The combined 
organic extracts were washed with two 25mL portions 
of water and with 25 mL of saturated aqueous sodium 
chloride solution and dried over sodium sulfate. The 
solvent was evaporated to yield 99.5 mg of crude yel 
low product, an orange solid. 
The product, which turned black upon standing, was 
dissolved in 5 mL of 9:1 ethyl acetate/hexanes v/v. 
After 16 hours, an orange precipitate had formed. The 
supernatant was removed by decantation and the result 
ing solids dried to give 25 mg (0.06 mmol, 54.5 percent) 
of 9beta-acetyl-7alpha,9alpha-dihydroxy-4-methoxy-6- 
nitro-5,6,6a,7,8,9,10,10a,11,12-decahydro-5,11,12-naph 
thacenetrione, mp 242 degrees centigrade (decomp). 
1H NMR (acetone D6): delta values 7.9 (dd, lh, aro 
matic), 7.7 (d, 1H, aromatic), 7.6 (d, 1H, aromatic), 6.2 
(d, J=4.5Hz, 1H, CHNO2), 5.5 (s, 0.5, OH), 4.9 (m,0.5, 
OH), 4.7 (m. 1H, CHOH), 4.0 (s, 3H, ArOCH3), 3.5 (ddd, J =4, 12, 13, Hz, 1H, COCHCH2), 2.8 (ddd, J =l, 
5, 13 Hz, 1H, COCHCH2 equatorial), 2.4 (ddd, 1H, 
COHCH2 equatorial), 2.3 (s, 3H, COCH3), 1.9 (m, 1H, 
NO2CHCH partially obscured by acetone quintet). 
IR (ATR thin film): 1709 (C=O), 1663, 1665, 1587, 
1560 (NO2) cm-l. 
UV-Vis (MeOH) maximum wavelengths: 424 nm. 
274, 258 nm. 
EXAMPLE 14 
7alpha,9alpha-(Di-O-isopropylidenyl)-4,5-dimethoxy 
9beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,10a, 
11-octahydro-11-naphthacenone 
A catalytic amount of pyridinium tosylate (5 mg) was 
added to a solution of 100 mg (0-20 mmol) of the 
25 
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decahydro-11-naphthacenone (example 11) in 20 mL of 60 
CH2Cl2. The mixture was refluxed for 6 hours while the 
color of the solution changed from light to shiny yel 
low. The reaction mixture was washed with water 
(2x20 mL) dried over Na2SO4 and the solvent was 
removed in vacuo. The yellow residue was recrystal 
lized from hexane: ethyl acetate (9:1) to give the octahy 
dro-11-naphthacenone as a mixture of 2 stereoisomers at 
C6 (88 mg, yield 94 percent). The isomer can be sepa 
65 
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rated by chromatography. Major isomer 85 percent 
m.p. 243-244 degrees centigrade. 
IR (KBr) 3262, 1733, 1616, 1572, 1563, 1554, 1501, 
1456, 1430, 1382, 1276, 1261, 1215 cm-l. 
NMR (360 MHz, CDCl3): major isomer 14.01(s, 1H), 
8.12(d, 1H), 7.49(t, 1H), 7.72(d, 1H), 6.35(d, J =4 
H2H), 4.73(d, 1H), 3.95(s, 3H), 3.27(m, 1H), 2.16(d, 
1H), 1.61(s, 3H), 1.30s, 3H), ppm.; (minor isomer 15 
percent) 13.34(s, 1H), 8.05(d, H), 7.47(t, 1H), 7.05(d, 
1H), 6.21(d, J 104 H2lH), 4.40(d, 1H), 3.91 (s, 3H), 
3.71(s, 3H), 3.66(d, H), 3.12(m, 2H), 2.53(s, 1H), 
2.19(m, 2H), 1.67(s, 3H), 1.37(s, 3H) ppm. 
UVVisi (MeOH) maximum wavelength: 230, 266, 
328, 396 mm. 
Anal. Calcd. for C25H5ON: C, 64.2, H, 5.39, N, 
3.00. Found: C, 64.9, H, 5.31, N: 3.04. 
EXAMPLE 5 
7alpha-9alpha-(Di-O-isopropylidenyl)-9beta-ethynyl 
11-hydroxy-4-methoxy-6-nitro-7,8,9,10-tetrahydro-5, 
12-nathacenedione 
A solution of 36 mg (0.075 mmol) of the octahydro 
11-naphthacenone and 60 mg (0.675 mmol) of NaHCP3 
in 10 mL of acetone was treated with a solution of 167 
mg (3mmol) of cerium ammonium nitrate (CAN) and 1 
mg of dichlorodicyanobenzoquinone (DDQ) in 2 mL of 
acetone added in one portion at 0 degrees centigrade. 
The reaction mixture was stirred at room temperature 
for 1.5 hours during which the color changed from 
shiny yellow to orange red, and then 25 mL of CH2Cl2 
was added. The mixture was filtered through over Cel 
ite. The organic layer was washed with saturated NaCl 
solution (2X20 mL), dried over Na2SO4, and evapo 
rated to give the tetrahydro-5,12-naphthacenedione as a 
red crystals (29 mg, 86 percent).mp greater than 258 
degrees centigrade (decomp). 
IR (KBr) 3306, 1620, 1588, 1529, 1491, 1369 cm-. 
1H NMR (360 MHz, CD2Cl21soo(s, 1H), 7.57(t, 1H), 
7.36(d, 1H), 4.50(m, 1H), 4.00(s, 3H), 3.12(m, 2H), 
2.65(m, 2H), 2.57(s, 1H), 1.68(s, 3H), 1.37(s, 3H) ppm. 
UV-Vis. (MeOH) maximum wavelength: 223, 240, 
248, 358, 440 nm; (CHCl3). 246, 370, 390, 416, 436 mm. 
EXAMPLE 16 
6-Desoxy-6-nitrodaunomycinone 
A solution of 12 mg of (0.027 mmol) of the tetrahy 
dro-5,12-naphthacenedione in 2.5 mL of tetrahydrofu 
ran was treated with 150 microL of H2SO4(3M) and 
then 5 mg of mercuric oxide at 0 degrees centigrade and 
stirred at room temperature for 24 hours. The turbit 
solution was neutralized with NaHCO3 to pH 8, and 
extracted with CH2Cl2 (10X) 15 mL). The extract was 
dried over Na2SO4, and evaporated to yield 6-desoxy-6- 
nitrodaunomycinone as a red solid (7 mg, 61.4 percent) 
. Flash chromatography on silica (60-200 mesh) eluting 
with 70:25:5(ethyl acetate:hexane:MeOH) afforded 2 
ng of the pure mycinone as red crystals. . 
IR (CHC13), 3364, 1708, 1662, 1615, 1591, 1525, 1499, 
1446, 1278, 1336 cm. 
1H NMR (360) MHz, CD2Cl2 15.15(s, 1H), 8.06 (d, 
1H), 7.820t, 1H), 7.42(d, 1H), 5.44(m, 1H, OH), 4.61(s, 
1H), 4.09(s, 3H), 3.79(m, 1H, OH), 3.21(d, 1H), 3.00(d, 
1H), 2.40(s, 3H), 2.30(d, 1H), 2.21(m, 1H) ppm. 
UVVisi maximum wavelengths: (CHC13) 245, 250, 
420, 446 nm; (MeOH)360, 385, 418, 441, 466 mm. 
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EXAMPLE 17 
6-Amino-9beta-ethynyl-4-methoxy-7alpha,9alpha,11 
trihydroxy-7,8,9,10-tetrahydro-5,12-naphthacenedione 
A solution of 15 mg (0.033 mmol) of 6-desoxy-6- 5 
nitrodaunomycinone and 96 mg (0.70 mmol) of 
NaOOCCH3:3H2O in 2 mL of CH3OH was treated 
with SnCl2.H2O (183 mg, 0.88 mmol), in 3 portions over 
a 90 min. at room temperature. During the addition the 
color of the solution changed to yellow. After the 10 
SnCl2 was added, the mixture was stirred for 1 h, and 
the solvent was evaporated. A mixture of 15ml of 
CH2Cl2 and 15mL of saturated aqueous NaHCO3 was 
added and the mixture was stirred for 30 min. During 
the stirring the color changed to pink and CO2 was 
evolved. 
The mixture was filled through Celite and extracted 
with CH2Cl2(3x20mL). The combined organic layers 
were washed with saturated aqueous NaCl, dried (Na2 
SO4), and evaporated to yield 14 mg of yellow solid. 
TLC showed that this was a mixture of 2 compounds. 
Flash chromatography using elution with hexane: ethyl 
aceate; MeOH(75:20:5) gave two compounds, the 6 
desoxy-6-nitro starting material (6mg), and 6-amino 
9beta-ethynyl-4-methoxy-5,7alpha,9alpha,11,12-pen 
tahydroxy-7,8,9,10-tetrahydronaphthacene (7.5mg) as 
shining yellow crystals (mp, 234-238 degrees centi 
grade). 
NMR: 14.1(s, 1H,OH)0), 13.4(s.2H,OH),8.1(d.1H), 
7.7(t, 1H),7.2(d, 1H),5.0(n, 1H)4.25(m, 1H,OH),404(s, 3H),3.62(m,2H,NH2),3.15(mlH,OH),2.95(q2H), 2.55(s, 
1H,C=CH), 1.96(m,2H).ppm. 
FT-IR (KBr) 3647,3375,3289, 1671, 1634, 1601, 1582 
cm-1. 
UV-Vis (CHCl3) 
446,422,274,250 nm. 
A saturated solution of 17.5 mg (0.032 mmol) ceric 
ammonium nitrate in acetone was added at 0 degrees 
centigrade to pentahydroxynaphthacene (7ng, 0.016 
immol) and NaHCO3(10mg) in 2 mL of acetone. The 
reaction mixture was stirred for 5 h at room tempera 
ture and then filtered through Celite and extracted with 
CH2Cl2 (7x10mL). Evaporation yielded 7 mg of the 
amino trihydroxy-5,12-naphthacenone as purple red 
crystals. 
1H NMR (CD2Cl2), 14.80(s, 1H,OH), 8.10 (d.1H), 
7.85(t, 1H),742(d.1H),5.35(d, 1H)4.30(d,1H,OH), 4.09 
(s.3H),3.57(m,2H),3.35(m,1H,OH),3.15(m,2H),2.55(s, 
1H), 1.95(n,2H)ppm. 
UV-Vis (CHCL3) maximum wavelength: 498, 442, so 
313, 269 mm. 
FT-IROKBr) 3644, 3277, 1671, 1631, 1580 cm-l. 
EXAMPLE 8 
Daunomycinone 
A solution of 7 mg (0.018 mmol) of the amino-5,12 
naphthacenedione and 1 mg of pyridinium tosylate in 
2nL of dimethoxyethane was treated with 15 microL of 
isoamylnitrite. As the mixture was stirred at room tem 
perature a purple precipitate formed, and 0.5mL of 60 
0.01N HCL was added, after stirring had been contin 
ued for 5h, the visible spectrum of the mixture showed 
absorption at 515 nm. Then HgO (40 mg, 0.18mmol), 
was added and stirring was continued for 24 h. The 
mixture was filtered through Celite, extracted with 65 
CH2Cl2 (15x10mL) and evaporated to yield 10 mg of 
red solid. Flash chromatogrphy with elution with ethyl 
acetate:hexane:MeOH (90: 5:5), followed by recrystali 
5 
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zation from CHCl3 gave 3 mg of daunomycinone (mp 
217-221 degrees centigrade). w 
1H-NMR (CD2Cl2, 360 MHz), 14.22 (s , 1H), 
13.47(2,1H), 8.21 (d.1H), 8.00 (t, 1H), 7.61 (d.1H), 5.48 
(m, 1H), 4.23 (s.3H), 4.07 (s.3H), 3.95 (d, 1H), 3.10 
(m,2H), 2.57 (s.3H), 2.30 (m,2H) ppm. 
FT-IR (CH2Cl2) 3540, 3053, 2927, 1712, 1616, 1578, 
1420 cm-l. 
UV-Visi (MeOH) maximum wavelength: 532, 495, 
476,287, 253,234mm. 
The preceding examples can be repeated with similar 
success by substituting the generically or specifically 
described reactants and/or operating conditions of this 
invention for those used in the preceding examples. 
Although preferred embodiments of the invention 
have been described with some particularity, many 
modifications and variations in the preferred embodi 
ment are possible without deviating from the invention. 
Is it therefore to be understood that, within the scope of 
the appended claims, the invention may be practiced 
other than as specifically described. 
What is claimed is: 
1. A process for the production of a compound of the 
general formula: 
wherein R1 is one of O-CCH3 or O-C-CH2OH.; 
R2 is one of daunosamine, or H; 
R3 is NO2; and 
R is OCH3, OH or H; 
comprising the steps of: 
preparing a mono ketal of a 1,4-naphthoquinone as 
the precursor of the CD rings; 
preparing a precursor for Ring A with C6 and C11 
attached and the stereochemistry at C7 and C9 
established and coupling it to CD and then con 
pleting ring B; 
said step of preparing a precursor for Ring A com 
prising the substeps of methylation of 5-oxocy 
clohex-2-enecarboxylic acid to methyl 5-oxocy 
clohex-2-enecarboxylate at a reaction temperature 
of between -20 to 20 degrees centigrade, trime 
thylsilylethynylation of said cyclohexenecarboxy 
late at a temperature of between -50 to -78 de 
grees centigrade after removal of water and etha 
nol to produce methyl cis-5-hydroxy-5-(trimethyl 
silylethynyl)cyclohex-2-enecarboxylate, epoxida 
tion to methyl cis-(2,3-epoxy-5-hydroxy)-5-(trime 
thylsilyl ethynyl)cyclohexane-1-carboxylate and 
opening of the resulting epoxide ring to give 
methyl cis-3,5-dihydroxy-5-(trimethylsilylethynyl) 
cyclohex-1-ene carboxylate. 
2. A process according to claim 1 in which the mono 
ketal of 1,4-naphthoquinone is the 4-monoketal of jug 
lone methyl ether. 
3. A process for the production of daunomycinone 
and related compounds in accordance with claim 1 in 
which the precursor for the A ring, with C6 and C1 
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attached and the stereochemistry at C, and C9 estab 
lished, has the general structure: 
wherein W is an ester or similar group capable of O 
acting as an electron pair acceptor in a Claisen 
condensation and related reactions; 
X is an umpolung equivalent of an acetyl group such 
as acetylide, trimethylsilylacetylide, ethyl or 
methyl vinyl ether, 2-methyl-1,3-dithiane or corre 
sponding dithioacetal or dithioacetal oxide, or cy 
naohydrin silyl ether or related compounds; 
Y is 2H, or if needed, a suitable protecting group for 
a 1,3 diol, such as a cyclic ketal e.g. acetonide or a 20 
cyclic ester e.g. boronate or carbonate; 
Z is a one carbon umpolung of carbonyl such as ni 
tromethyl, 1,3-dithiane or the corresponding sulf 
oxide of the 1,3-dithiane, a cyanohydrin silyl ether 
or related compounds. 
4. A process for the production of daunomycinone, 
comprising the steps of 
methylation of 5-oxocyclohex-2-enecarboxylic acid 
to methyl 5-oxocyclohex-2-enecarboxylate at a 
reaction temperature of between -20 to 20 de grees centigrade, trimethylsilylethynylation of said 
oxocyclohexenecarboxylate at a temperature of 
between -50 to -78 degrees centigrade after 
removal of water and ethanol to produce methyl 
cis-5-hydroxy-5-(trimethylsilylethynyl)cyclohex-2- 
enecarboxylate, conversion to an epoxide and 
opening of the resulting epoxide ring to give 
methyl cis-3,5-dihydroxy-5-(trimethylsilyl)e- 
thynylcyclohex-1-enecarboxylate; 
addition of nitromethane to the said dihydroxyethy 
nyl ester to give methyl 3alpha,5alpha-dihydroxy 
5beta-(trimethylsilylethynyl)-2alpha-nitromethyl 
hexane-1beta-carboxylate; 
formation of the acetonide of methyl 3alpha,5alpha dihydroxy-5-beta-(trimethylsilylethynyl)-2alpha 
nitromethylcyclohexane-1-beta-carboxylate; 
condensation of the said acetonide with 1,4-dihydro 
4,4,5-trimethoxy-1-oxonaphthalene in the presence 
of 1,8-diazabicyclo5.4.0 undec-7-ene in an aprotic 
solvent to produce 3-2beta-carbomethoxy-4-beta 
ethynyl-4-alpha,6alpha-(di-O-isopropylidenyl)cy 
clohexan-1alpha-yl)-nitromethyl-4,4,5-trimethoxy 
1-oxo-1,2,3,4-tetrahydronaphthalene; 
cyclizing said 1-oxotetrahydronaphthalene to pro 
duce 7alpha,9alpha-(di-O-isopropylidenyl)-9beta 
ethynyl-12-hydroxy-6-nitro-4,5,5-trimethoxy 
5,5a,6, 6a,7,8,9,10,10a, 11-decahydro-11-naphthace 
none; 
converting said decahydro-11-naphthacenone to 7al 
pha,9alpha-(di-O-isopropylidenyl)-4,5-dimethoxy 
9beta-ethynyl-12-hydroxy-6-nitro-6,6a,7,8,9,10,- 
10a, 11-octahydro-11-naphthacenone; 
oxidizing said octahydro-11-naphthacenone to 7al 
pha,9alpha-(di-O-isopropylidenyl)-9beta-ethynyl 
11-hydroxy-4-methoxy-6-nitro-7,8,9,10-tetrahy 
dro-5,12-naphthacenedione; 
hydrolysing said 5,12-naphthacenedione to 6-desoxy 
6-nitrodaunomycinone; 
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reducing said nitrodaunomycinone to 6-desoxy-6- 
aminodaunomycinone; 
converting said aminodaunomycinone to the 6 
diazoniumdaunomycinone and from this obtaining 
daunomycinone, 6-desoxydaunomycinone, the 6 
desoxy-6-halodaunomycinones, 6-desoxy-6- 
cyanodaunomycinone and other 6-analogues easily 
derived from these products. 
5. The process of claim 4, wherein the aprotic solvent 
for condensing the acetonide with 1,4-dihydro-4,4,5- 
trimethoxy-1-oxonaphthalene can be acetonitrile, dime 
thylsulfoxide, NNdimethylpropyleneurea or hexame 
thylphosphoramide. 
6. The process of claim 4, wherein the aprotic solvent 
for condensing the acetonide is acetonitrile. 
7. The process of claim 4, wherein said 1-oxotetrahy 
dronaphthalene is cyclized with an alkalimetal alkoxide 
of 1-6 carbon atoms. 
8. The process of claim 7, wherein said alkali metal 
alkoxide is sodium methoxide produced by potassium or 
sodium hydride and a catalytic quantity of methanol in 
toluene or other aprotic solvent. 
9. The process of claim 4, wherein said decahydro-11 
naphthacenone is converted to 7alpha,9alpha-(di-O-iso 
propylidenyl)-4,5-dimethoxy-9beta-ethynyl-12 
hydroxy-6-nitro-6,6a,7,8,9,10,10a, 11-octahydro-11 
naphthacenone under acidic conditions. 
10. The process of claim 4, wherein said decahydro 
11-naphthacenone is converted into said octahydro-11 
naphthacenone by treatment with pyridinium tosylate. 
11. The process of claim 4, wherein said octahydro 
11-naphthacenone is oxidized to 7alpha, 9alpha-(di-O- isopropylidenyl)-9beta-ethynyl-11-hydroxy-4-methoxy 
6-nitro-7,8,9,10-tetrahydro-5,12-naphthacenedione with 
reagents such as cerium ammonium nitrate or thallium 
trinitrate or iodobenzenediacetate using with each oxi 
dant a catalytic quantity of 2,3-dichloro-5,6- 
dicyanobenzoquinone. 
12. The process of claim 4, wherein the said di-O-iso propylidenylethynyltetrahydro-5,12-naphthacenedione 
is hydrolysed by acid in the presence of mercuric oxide 
to 6-desoxy-6-nitrodaunomycinone. 
13. The process of claim 4, wherein the said ni 
trodaunomycinone is reduced to 6-amino-6-desox 
ydaunomycinone using SnCl2 in the presence of sodium 
acetate in methanol. 
14. The process of claim 4, wherein the said 
aminodaunomycinone is converted via a diazonium 
intermediate into one of daunomycinone, 6-desox 
ydaunomycinone, the 6-desoxy- 6-halodaunomyci 
nones, 6-desoxy-6-cyanodaunomycinone and com 
pounds easily derived from these products. 
15. The process of claim 14, wherein said diazonium 
compound is formed from the amino daunomycinone in 
1,2-dimethoxyethone using amyl nitrite in the presence 
of pyridinium tosylate. 
16. The process of claim 4 wherein said decahydro 
11-naphthacenone is hydrolyzed by HgO in the pres 
ence of acid to form 9beta-acetyl-4,5-dimethoxy-6- 
nitro-7alpha,9alpha, 12-trihydroxy-6,6a, 7,8,9,10,10a, 11 
octahydro-11-naphthacenone. 
17. The process of claim 4, wherein the said 9beta 
acetyloctahydro-11-naphthacenone is oxidized to 6 
desoxy-6-nitrodaunomycinone with thallium trinitrate 
or cerium ammonium nitrate or iodobenzenediacetate 
using with each oxidant a catalytic quantity of 2,3- dichloro-5,6-dicyanobenzoquinone. 
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18. The process of claim 4 wherein said 9beta 
acetyloctahydro-11-naphthacenone is oxidized with 
cerium ammonium nitrate or thallium trinitrate or iodo 
benzene diacetate to 9beta-acetyl-7alpha,9alpha-dihy 
droxy-4-methoxy-6-nitro-6,6a,7,8, 9,10,10a, 11-octahy 
dro-5,11,12-naphthacenetrione. 
19. The process of claim 4, wherein the alkali metal 
alkoxide is sodium methoxide generated from sodium 
hydride and a catalytic quantity of methanol in toluene. 
20. The process of claim 4, wherein the aprotic sol 
vent for condensing the acetonide with 1,4-dihydro 
4,4,5-trimethoxy-1-oxonaphthalene is acetonitrile; the 
thus-produced 1-oxotetrahydronaphthalene is cyclized 
with sodium methoxide; the thus-produced decahydro 
11-naphthacenone is converted to the 9beta-acetyloc 
tahydro-1-naphthacenone with mercuric oxide in an 
acidic medium; the thus-produced 9beta-acetyloctahy 
dro-11-naphthacenone is oxidized to the decahydro 
5,11,12-naphthacenetrione with thallium trinitrate or 
cerium ammonium nitrate or iodobenzenediacetate; the 
thusproduced decahydro-5,11,12-naphthacenetrione is 
converted to a daunomycinone titanium compound by a 
Nef reaction, using sodium methoxide, and a thus 
formed intermediate is treated with titanium trichloride. 
21. A process of synthesizing methyl cis-3,5-dihy 
droxy-5-(trimethylsilylethynyl)cyclohex-1-ene-1-car 
boxylate from m-anisic acid comprising the steps of 
Birch reduction with lithium in ammonia to produce 
5-oxocyclohex-2-ene-1-carboxylic acid, methylation of 
said cyclohex-2-ene-1-carboxylic acid to methyl 5-oxo 
cyclohex-2-ene-1-carboxylate with diazomethane, 
trimethylsilylethynylation of said cyclohex-2-ene-l-car 
boxylate with cerium dichloride trimethylsilylacetylene 
to produce methyl cis-5-hydroxy-5-(trimethylsilyle 
thynyl)cyclohex-2-ene-1-carboxylats, and conversion 
to an epoxide and opening of the resulting epoxide ring 
to give said cyclohex-1-ene-1-carboxylate. 
22. The process of claim 21 wherein: 
the reaction mixture is kept cold during esterification 
with diazomethane and the ethanol that is present 
in the esterification reaction mixture is removed by 
azeotropic distillation with benzene; 
methyl ester is treated with cerium dichloride trime 
thylsilylacetylene at a low temperature to prevent 
formation of a lactone; 
the epoxide is formed by oxidation with t-butyl hy 
droperoxide in the presence of molybdenum hex 
acarbonyl catalyst and isolating the thus-produced 
epoxide; and 
the epoxide ring is opened with 1,8-diazabicyclo 
5.4.0-undec-7-ene or 1,5-diazabicyclo 4.3.0non 
5-ene or sodium methoxide in methanol; the latter 
conditions also remove the trimethysilyl group to 
give methyl cis 3,5-dihydroxy-5-ethynylcyclohex 
1-ene-1-carboxylate. 
23. A process for producing methyl 3alpha,5alpha 
dihydroxy-5beta-(trimethylsilylethynyl)-2alpha 
nitromethylcyclohexane-1beta-carboxylate comprising 
the steps of reacting methyl cis-3,5-dihydroxy-5-(trime 
thylsilylethynyl)cyclohex-1-ene-1-carboxylate with ni 
tromethane in the presence of 1,8-diazabicyclo[5.4.0]un 
dec-7-ene or 1,5-diazabicyclo-4.3.0non-5-ene or sodium 
hydride in an aprotic solvent that can form hydrogen 
bonds with hydropyl groups. 
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24. A process for producing methyl 3alpha,5alpha 
dihydroxy-5beta-ethynyl-2alpha-nitro-methylcyclohex 
ane-1beta-carboxylate comprising the steps of reacting 
methyl cis-3,5-dihydroxy-5-beta-ethynylcyclohex 
1-ene-1-carboxylate with nitromethane in the presence 
of 1,8-diazabicyclo5.4.0]undec-7-ene or 1,5-diazabicy 
cio 4.3.0 non-5-ene or sodium hydride or potassium 
hydride in an aprotic solvent that can form hydrogen 
bonds with hydroxyl groups. 
25. The process of claim 23 carried out in the pres 
ence of 1,8-diazabicyclo[5.4.0]undec-7-ene, wherein the 
aprotic solvent is dimethyl sulfoxide. 
26. The process of claim 23 carried out in the pres 
ence of sodium hydride, wherein the aprotic solvent is 
dimethyl sulfoxide. 
27. A process for preparing methyl 3-alpha,5-alpha 
dihydroxy-5-beta-(trimethylsilylethynyl)-2alpha 
nitromethylcyclohexane-1-beta-carboxylate comprising 
reacting methyl cis-(2,3alpha-epoxy-5alpha-hydroxy 
5beta-(trimethylsilylethynyl)cyclohexane-1alpha-car 
boxylate with nitromethane in the presence of 1,8- 
diazabicyclo5.4.0]undec-7-ene in an aprotic solvent. 
28. The process of claim 27, wherein the aprotic sol 
vent is dimethyl sulfoxide. 
29. Methyl 3alpha,5alpha-dihydroxy-5beta-(trime 
thylsilylethynyl)-2alpha-nitromethylcyclohexane 
beta-carboxylate. 
30. The 3,5-acetonide of methyl 3alpha,5alpha-dihy droxy-5beta-(trimethylsilylethynyl)-2alpha-nitrome 
thylcyclohexane-1beta-carboxylate. 
31. A process for preparing the compound of claim 
30, comprising reacting 3alpha,5alpha-dihydroxy-5beta (trimethylsilylethynyl)-2alpha-nitromethylcyclohex 
ane-1beta-carboxylate with an acetonide-forming rea 
gent. 
32. The process of claim 31, wherein the acetonide 
forming reagent is 2-methoxypropene and acetonide 
formation is carried out in the presence of pyridinium 
tosylate. 
33. The process of converting 5-alkoxy-1-naphthol to 
a corresponding juglone alkyl ether 4-acetal, by reac 
tion thallium trinitrate or iodobenzenediacetate in tri 
methyl orthoformate and the appropriate solvent to 
provide the ketal. 
34. The process of claim 33, wherein the 5-alkoxy-1- 
naphthol is 5-methoxy-1-naphthol, the oxident is iodo 
benzenediacetate, the solvent is methanol and trime 
thylorthoformate and sodium bicarbonate is present, 
and the thus-produced juglone alkyl ether ketal is 1,4- dihydro-4,4,5-trimethoxy-1-oxonaphthalene. 
35. The process of claim 24 carried out in the pres 
ence of 1,8-diazabicyclo5.4.0]undec-7-ene, wherein the 
aprotic solvent is dimethyl sulfoxide. 
36. The process of claim 24 carried out in the pres 
ence of sodium hydride, wherein the aprotic solvent is 
dimethyl sulfoxide. 
37. A method according to claim 1 further compris 
ing the steps of 
adding nitromethane to the said dihydroxyethynyl 
ester to give methyl 3alpha,5alpha-dihydroxy 
5beta-(trimethylsilylethynyl)-2alpha-nitromethyl 
hexane-1beta-carboxylate; and 
forming the acetonide of methyl 3alpha,5alpha-dihy 
droxy-5beta-(trimethylsilylethynyl)-2alpha 
nitromethylcyclohexane-1beta-carboxylate. 
